Table 3.
Type of parathyroid pathology that determined PHPT in the case series
| Parathyroid pathologies | Patients (%) |
|---|---|
| SGD (single adenoma—SA) (126 parathyroids removed) | 126 (92.6) |
| Superior parathyroids | 38 (30) |
| Inferior parathyroids | 88 (70) |
| Right Inferior | 49 (56) |
| Left Inferior | 39 (44) |
| Ectopic parathyroids | 22 (17.4% of 126 removed SAs) |
| Superior mediastinal | 9 |
| Intrathyroidal | 6 |
| Tracheo-esophageal | 5 |
| Retro-esophageal/paratracheal | 2 |
| MGD (22 parathyroids removed) | 10 (7.4) |
| Double Adenoma (DA) | 6 |
| Adenoma + Hyperplasia | 3 |
| Diffused Hyperplasia (MEN1) | 1 |
| Ectopic parathyroids | 3 (13.6% of the 22 pathological parathyroids removed) |
| Paratracheal | 1 |
| Retroesophageal | 1 |
| Superior Mediastinal | 1 |
| Ectopic pathological parathyroids (EPP) (in the whole series) | 25 (17% of all 148 pathological parathyroids removed) |
| Inferior parathyroids | 17 (68) |
| Superior parathyroids | 8 (32) |
| Definitive histological examination (operating piece—148 removed pathological parathyroids) | |
| Adenoma | 141 (95.2) |
| Hyperplasia | 7 (4.8) |